Can the New Alzheimer’s Drugs Work Even Better?
March 10, 2025
Why Did Europe Finally Choose Lecanemab for Alzheimer’s?
Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart? (Video)
Source:
Related:
Advantages of Namzaric for Dementia
February 20, 2025
Alzheimer’s, Bathroom Trips & Cholinesterase Inhibitors
February 19, 2025
Leqembi & Kisunla: Extending Independent Living
February 16, 2025
Leqembi: Europe Checks It’s Safety; U.S. Approves Monthly Doses
February 3, 2025
What’s Ahead for Alzheimer’s Drugs in 2025
January 12, 2025
Email me when people comment
Login
0 Comments
Edited by:
P. Berger
Caring for dementias such as Alzheimer's among family and friends, Peter committed to help preserve the dignity of people affected by Alzheimer's. AlzheimersWeekly.com is the fruit of that commitment.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
You May LIke:
Diet
Caffeine Boosts Dementia-Fighting Enzyme
DIET VIDEO + ARTICLE: Caffeine increases the enzyme called NMNAT2 in the brain. This creates a chemical ‘blockade’ against dementia. Learn how caffeine and 23
1 Comment
Uncategorized
A.I. Detects Early Signs of Alzheimer’s
Scientists found a way to predict Alzheimer’s up to seven years before symptoms appear using A.I.
No Comments
Progress
Bigger is Better: Brain Size Up 7%, Dementia Down 25%
In a span of 40 years, why did average brain size increase and dementia rates drop? A new UC-Davis study explores environmental factors behind this silent revolution.
1 Comment
Drugs
Agitation in Alzheimer’s: Rexulti® Makes Meaningful Improvements
In a new Alzheimer’s study, Rexulti (brexpiprazole) significantly reduced agitation. Learn the kinds of agitation it reduced and by how much.
No Comments
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On